Suppr超能文献

肾上腺素对院外心脏骤停患者的治疗效果和不良反应:系统评价和荟萃分析。

Therapeutic and adverse effects of adrenaline on patients who suffer out-of-hospital cardiac arrest: a systematic review and meta-analysis.

机构信息

Emergency Department, Affiliated Hospital of Zunyi Medical University, Zunyi, 563003, Guizhou, China.

Emergency Department, KweiChow Moutai Hospital, Renhuai, 564501, Guizhou, China.

出版信息

Eur J Med Res. 2023 Jan 12;28(1):24. doi: 10.1186/s40001-022-00974-8.

Abstract

OBJECTIVE

The efficacy and safety of epinephrine in patients with out-of-hospital cardiac arrest (OHCA) remains controversial. The meta-analysis was used to comprehensively appraise the influence of epinephrine in OHCA patients.

METHODS

We searched all randomized controlled and cohort studies published by PubMed, EMBASE, and Cochrane Library from the inception to August 2022 on the prognostic impact of epinephrine on patients with OHCA. Survival to discharge was the primary outcome, while the return of spontaneous circulation (ROSC) and favorable neurological outcome were secondary outcomes.

RESULTS

The meta-analysis included 18 studies involving 863,952 patients. OHCA patients with adrenaline had an observably improved chance of ROSC (RR 2.81; 95% CI 2.21-3.57; P = 0.001) in randomized controlled studies, but the difference in survival to discharge (RR 1.27; 95% CI 0.58-2.78; P = 0.55) and favorable neurological outcomes (RR 1.21; 95% CI 0.90-1.62; P = 0.21) between the two groups was not statistically significant. In cohort studies, the rate of ROSC (RR 1.62; 95% CI 1.14-2.30; P = 0.007) increased significantly with the adrenaline group, while survival to discharge (RR 0.73; 95% CI 0.55-0.98; P = 0.03) and favorable cerebral function (RR 0.42; 95% CI 0.30-0.58; P = 0.001) were lower than the non-adrenaline group.

CONCLUSION

We found that both the randomized controlled trials (RCTs) and cohort studies showed that adrenaline increased ROSC in OHCA patients. However, they were unable to agree on a long-term prognosis. The cohort studies showed that adrenaline had an adverse effect on the long-term prognosis of OHCA patients (discharge survival rate and good neurological prognosis), but adrenaline had no adverse effect in the RCTs. In addition to the differences in research methods, there are also some potential confounding factors in the included studies. Therefore, more high-quality studies are needed to fully confirm the effect of adrenaline on the long-term results of OHCA.

摘要

目的

肾上腺素在院外心脏骤停(OHCA)患者中的疗效和安全性仍存在争议。本荟萃分析旨在全面评估肾上腺素对 OHCA 患者的影响。

方法

我们检索了 PubMed、EMBASE 和 Cochrane Library 自成立以来至 2022 年 8 月发表的所有关于肾上腺素对 OHCA 患者预后影响的随机对照试验和队列研究。出院存活率为主要结局,而自主循环恢复(ROSC)和良好的神经功能结局为次要结局。

结果

荟萃分析纳入了 18 项涉及 863952 名患者的研究。随机对照研究显示,OHCA 患者使用肾上腺素可显著提高 ROSC 几率(RR 2.81;95%CI 2.21-3.57;P=0.001),但两组间出院存活率(RR 1.27;95%CI 0.58-2.78;P=0.55)和良好的神经功能结局(RR 1.21;95%CI 0.90-1.62;P=0.21)的差异无统计学意义。在队列研究中,肾上腺素组 ROSC 发生率(RR 1.62;95%CI 1.14-2.30;P=0.007)显著升高,而出院存活率(RR 0.73;95%CI 0.55-0.98;P=0.03)和良好的脑功能(RR 0.42;95%CI 0.30-0.58;P=0.001)均低于非肾上腺素组。

结论

本研究发现,随机对照试验(RCT)和队列研究均表明肾上腺素可增加 OHCA 患者的 ROSC,但对于长期预后,两者意见不一。队列研究表明,肾上腺素对 OHCA 患者的长期预后(出院存活率和良好的神经预后)有不良影响,但在 RCT 中肾上腺素无不良影响。除研究方法的差异外,纳入研究还存在一些潜在的混杂因素。因此,需要更多高质量的研究来充分证实肾上腺素对 OHCA 长期结果的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65e/9835354/0fab729a992b/40001_2022_974_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验